NDC 68071-3125

IBU

Ibuprofen

IBU is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Nucare Pharmaceuticals,inc.. The primary component is Ibuprofen.

Product ID68071-3125_4a649ea8-9bf2-43d1-e054-00144ff8d46c
NDC68071-3125
Product TypeHuman Prescription Drug
Proprietary NameIBU
Generic NameIbuprofen
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2008-11-20
Marketing CategoryANDA / ANDA
Application NumberANDA075682
Labeler NameNuCare Pharmaceuticals,Inc.
Substance NameIBUPROFEN
Active Ingredient Strength600 mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 68071-3125-1

21 TABLET in 1 BOTTLE (68071-3125-1)
Marketing Start Date2008-11-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68071-3125-4 [68071312504]

IBU TABLET
Marketing CategoryANDA
Application NumberANDA075682
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-11-20
Inactivation Date2020-01-31

NDC 68071-3125-2 [68071312502]

IBU TABLET
Marketing CategoryANDA
Application NumberANDA075682
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-11-20
Inactivation Date2020-01-31

NDC 68071-3125-3 [68071312503]

IBU TABLET
Marketing CategoryANDA
Application NumberANDA075682
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-11-20
Inactivation Date2020-01-31

NDC 68071-3125-9 [68071312509]

IBU TABLET
Marketing CategoryANDA
Application NumberANDA075682
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-11-20
Inactivation Date2020-01-31

NDC 68071-3125-5 [68071312505]

IBU TABLET
Marketing CategoryANDA
Application NumberANDA075682
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-11-20
Inactivation Date2020-01-31

NDC 68071-3125-7 [68071312507]

IBU TABLET
Marketing CategoryANDA
Application NumberANDA075682
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-11-20
Inactivation Date2020-01-31

NDC 68071-3125-1 [68071312501]

IBU TABLET
Marketing CategoryANDA
Application NumberANDA075682
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-11-20
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
IBUPROFEN600 mg/1

OpenFDA Data

SPL SET ID:4a649ea8-9bf1-43d1-e054-00144ff8d46c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197806
  • 206913
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • NUI Code
  • N0000000160
  • N0000175722
  • N0000175721
  • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Anti-Inflammatory Agents
    • Non-Steroidal [CS]

    NDC Crossover Matching brand name "IBU" or generic name "Ibuprofen"

    NDCBrand NameGeneric Name
    68071-1827IBUIBU
    68071-3053IBUIBU
    68071-3125IBUIBU
    68071-3172IBUIBU
    70518-0490IBUIBU
    70518-1145IBUIBU
    10544-071IBUIBU
    10544-625IBUIBU
    35356-699IBUIBU
    43353-273IBUIBU
    49999-042IBUIBU
    50436-0684IBUIBU
    50436-4605IBUIBU
    50436-4604IBUIBU
    53002-3370IBUIBU
    53002-3980IBUIBU
    53002-3010IBUIBU
    53217-366IBUIBU
    55111-683IBUIBU
    55111-684IBUIBU
    55111-682IBUIBU
    60429-219IBUIBU
    60429-220IBUIBU
    60429-221IBUIBU
    60760-135IBUIBU
    60760-076IBUIBU
    61919-621IBUIBU
    63187-614IBUIBU
    66267-116IBUIBU
    66267-117IBUIBU
    66267-963IBUIBU
    66267-793IBUIBU
    66267-795IBUIBU
    66267-964IBUIBU
    66267-794IBUIBU
    67296-1217IBUIBU
    67296-0877IBUIBU
    67296-0913IBUIBU
    70934-195IBUIBU
    71610-275IBUIBU
    0615-8116IBUIBU
    0615-8115IBUIBU
    0615-8117IBUIBU
    50090-4341IBUIBU
    50090-4333IBUIBU
    0113-1461basic care childrens ibuprofenIbuprofen
    0113-7619basic care childrens ibuprofenibuprofen
    0113-7660basic care childrens ibuprofenIbuprofen
    0113-7897Basic Care childrens ibuprofenIbuprofen
    0113-0788Basic Care ibuprofenIbuprofen

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.